We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
Suven Life Sciences has announced that it has received a product patent by China and the US each for a new chemical entity (NCE) for treatment of disorders associated with neurodegenerative diseases.
Suven Life Sciences has announced that it has received a product patent by China and the US each for a new chemical entity (NCE) for treatment of disorders associated with neurodegenerative diseases.